PAKOLA STEVE sold RGNX

June 29, 2026 · Form 4 insider transaction

PAKOLA STEVE sold 19,608 shares of REGENXBIO Inc. at $11.04 per share, a transaction worth $216.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Disposed (sell-side)
Shares
19,608
Price
$11.04
Total value
$216.5K
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 29, 2026
Filing dateJuly 1, 2026
Shares owned after213,009
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

This transaction was effected pursuant to a Rule 10b5-1 trading plan.; This transaction was executed in multiple trades at prices ranging from $11.00 to $11.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

View the original Form 4 on SEC EDGAR